Use of a Population Pharmacokinetic Approach for the Clinical Development of a Fixed-Dose Subcutaneous Formulation of Trastuzumab

por Hourcade-Potelleret, F, Lemenuel-Diot, A, McIntyre, C, Brewster, M, Lum, B, Bittner, B
Publicado 2014